Corrigendum to ‘Current Use and Trends in Hematopoietic Cell Transplantation in the United States’ [Transplantation and Cellular Therapy 26/8 (2020) e177-e182]
Janet Brunner, Saurabh Chhabra(Medical College of Wisconsin), Waleska S. Pérez(Medical College of Wisconsin), Mehdi Hamadani(Medical College of Wisconsin), Parameswaran Hari(Medical College of Wisconsin), Bronwen E. Shaw(Royal Marsden NHS Foundation Trust), Anita D’Souza, Mary Eapen(Medical College of Wisconsin), Patricia Steinert(Medical College of Wisconsin), Mukta Arora(Fairview Health Services), Wael Saber(Medical College of Wisconsin), Daniel J. Weisdorf(University of Minnesota), J. Douglas Rizzo, Marcelo C. Pasquini(Cleveland Clinic), Stephen R. Spellman(National Marrow Donor Program), Mary M. Horowitz(Medical College of Wisconsin), Rachel Phelan(Children's Hospital of Wisconsin), Caitrin Fretham(National Marrow Donor Program), Steven M. Devine(National Marrow Donor Program), Stephanie J. Lee, Marcie Riches(Medical College of Wisconsin)
Cited by 0
Related Papers
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
|Transplantation and Cellular Therapy|2018|3.6k
Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma
|New England Journal of Medicine|2012|1.2k
Solid Cancers after Bone Marrow Transplantation
|New England Journal of Medicine|1997|968